Clinically proven skin brands launched

Who doesn’t aim and dream of having a fair, flawless, wrinkle- and blemish-free skin?

Unfortunately, not all of us are blessed to have skin as white as snow. Add to that, the pollution and daily grind that one has to face every single day make it a lot more difficult to maintain a clear and healthy skin.

With such dilemma, a big amount of an individual’s money is spent on vanity products. But the sad reality is that not all of these products live up to their promise of giving one the clear, smooth and blemish-free skin he/she is dreaming of.

The good news however is that we now have more dermatologists and pharmaceutical firms that continue to provide real treatments, information and provide certain products to use for certain types of skin condition and concern.

Full support

Recently, global pharmaceutical commercialization services company Invida conveyed its full support for dermatologists in the Asia-Pacific region through its Invida Skin Science line of products.

Invida Skin Science is a range of high-quality, clinically proven skin care brands for scar treatment, wound healing and skin aging.

“We are privileged to support skin care experts in the region with our comprehensive range of clinically proven safe and effective dermatological products,” said Dr. Maaliddin B. Biruar, Medical and Scientific Affairs director, Invida Philippines.

The different products were launched during a roundtable discussion that was organized in connection with the 20th Regional Conference of Dermatology (RCD).

First held in 1972, the biennial RCD aims to maintain the highest professional standards for dermatologists within the region and foster cooperation among members of the different national dermatological societies in Southeast Asia and Australia.

“This collegial gathering of respected skin care experts in the Asia-Pacific region is the perfect venue to launch our range of science-based skin care products,” said Ninia E. Torres, country head, Invida Philippines.

Product line

Unlike other dermatological products which can be bought over the counter, Invida Skin Science offers a range of skin therapeutic and aesthetic products that are prescribed by dermatologists, plastic surgeons and obstetricians.

It includes Atopiclair, a steroid-free, preservative-free and scent-free emollient cream for the treatment of mild to moderate atopic dermatitis; Dermatix Ultra, a transparent, fast-drying silicone gel with advanced scar treatment formula; Kinerase, an anti-aging cosmeceutical containing the plant growth factor kinetin for the treatment of fine lines, wrinkles, skin tex ture and blotchiness; Papulex, a specially formulated line of products that keeps acne-prone skin in good condition through its cleansing, treating and protecting action; and other products for the treatment of skin infections and glabellar lines.

“Various clinical studies show that Papulex  is an effective and safe treatment for acne. Nicotinamide [the active ingredient of Papulex] has no photoallergic and phototoxic effects, making Papulex safe to use even in summertime,” explained Prof. Stefano Veraldi, past president of the Italian Acne Board and secretary of the Associazione Lombarda di Dermatologia e Venereologia.

Delay aging

“Clinical trials have shown that kinetin [the active ingredient of Kinerase] can delay and even reverse the effects of aging in human skin cells,” said Dr. Priya Sen, consultant dermatologist and laser surgeon, National Skin Center, Singapore.

Invida was formed in 2005 by a powerful strategic partnership between Quintiles, the world’s leading pharmaceutical services organization; Temasek Holdings, one of the world’s largest investment companies, and Zuellig Group, the largest pharmaceutical distribution and supply chain management network in Asia Pacific. Invida aims to become the leading provider of important healthcare brands and services to improve the lives of people in the region.

In November 2011, the Florence-based Italian multinational company Menarini Group completed its acquisition of Invida.

Read more...